2018 PHA Outstanding Members Awards Presented During Conference

2018-07-13T19:33:58+00:00 July 12th, 2018|

The Pulmonary Hypertension Association (PHA) would not be able to achieve its work without the dedication and excellence of the entire PH community. The individuals recognized during a June 30 awards ceremony at PHA’s 2018 International PH Conference and Scientific Sessions have exemplified dedication and service to the community and the association. They have

NEW! PHA Roadmap to Hope a must-read resource for people newly diagnosed with PH

2018-06-22T18:27:02+00:00 June 20th, 2018|

The Pulmonary Hypertension Association (PHA) has created a new resource for people who have recently been – or are at risk of being – diagnosed with pulmonary hypertension (PH). The Roadmap to Hope: a guide for people recently diagnosed with pulmonary hypertension (PH) answers the question, “I have PH – now what do I

Conference Speaker Spotlight: Norman Stockbridge, M.D., Ph.D.

2018-06-20T16:00:31+00:00 June 20th, 2018|

The Pulmonary Hypertension Association (PHA) Scientific Sessions Planning Committee has announced Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiovascular and Renal Products (DCaRP) in the Center for Drug Evaluation and Research of the Food and Drug Administration (FDA), as a speaker at PHA’s 2018 International PH Conference and Scientific Sessions. DCaRP is responsible

Conference Speaker Spotlight: Sagar Lonial, M.D., FACP

2018-06-15T20:23:38+00:00 June 15th, 2018|

Prompted by recent successes in the field of oncology in precision medicine, the Pulmonary Hypertension Association’s (PHA) Scientific Sessions Committee has invited Sagar Lonial, M.D., FACP, an internationally-recognized leading authority in multiple myeloma treatment and research, to provide his insight in the field of PH to health care providers. Dr. Lonial’s research has focused

PHA-Funded Research Discovers Link Between Cancer Protein and Fibrosis in PAH Patients

2018-06-15T20:26:20+00:00 June 15th, 2018|

A new molecular mechanism in the development of World Health Organization (WHO) Group 1 pulmonary hypertension (PH) – pulmonary arterial hypertension (PAH) – has been discovered by investigators from the Brigham and Women’s Hospital, through work funded in part by the Pulmonary Hypertension Association (PHA). NEDD9, a protein that was discovered in 1992 and has

Switching Gears, a Different Kind of Support Group Leader

2018-06-15T20:37:12+00:00 June 14th, 2018|

This article by Emily K. Outtarac, Administrative Assistant, Medical Services, first appeared in Issue 1 2018 of Pathlight magazine. Become a member of PHA to receive this quarterly publication full of patient profiles, medical information and tips for living with pulmonary hypertension. The PHA Support Group program offers in-person meetings to exchange tips, learn

Conference Attendee Profile: The University of Michigan Pulmonary Hypertension Team

2018-06-11T14:20:05+00:00 June 8th, 2018|

PHA News periodically runs Q&A style profiles of pulmonary hypertension (PH) health care professionals and programs that are participating in PHA’s 2018 International PH Conference and Scientific Sessions. By Susie McDevitt, NP Tell us your program’s name and a little about your staff. University of Michigan (UM) Pulmonary Hypertension Program The University of Michigan pulmonary

Pediatric Focus at PHA’s 2018 International PH Conference and Scientific Sessions

2018-06-08T19:19:29+00:00 June 7th, 2018|

Steven H. Abman, M.D. David B. Frank, M.D., Ph.D. Stephanie Siehr Handler, M.D. Uyen Truong, M.D. Erika S. Berman Rosenzweig, M.D. Despite recent milestones in the field of pediatric PH, knowledge and treatment options still lag behind that of adult PH. This year’s

Conference Speaker Spotlight: Michael Snyder, Ph.D.

2018-06-01T17:00:29+00:00 May 21st, 2018|

Because genetics are essential to the discussion about precision medicine, the Scientific Sessions Committee is excited to feature Michal Snyder, Ph.D., Stanford Ascherman professor and chair of Genetics and director of the Center of Genomics and Personalized Medicine at Stanford University School of Medicine, during the session block “Omics and Wearable in Pulmonary Hypertension: